Search
for
Sort by
Research 421–450 of 691
- Abstracts from the current global literature: Finasteride and sexual dysfunction
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- TERAPINĖS BOTULINO NEUROTOKSINO A PANAUDOJIMO GALIMYBĖS
- Compounded topical finasteride-related AEs
- Finasteride- versus dutasteride-related sexual AEs
- Finasteride-related sexual and neuropsychiatric AEs
- Reminder of finasteride-related psychiatric AEs and sexual dysfunction
- Iatrogen male infertility
- Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational Study
- EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments
- SP0011 Long-Term Glucocorticoid Use and The Skin
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Patient-reported outcomes of adverse events after perioperative chemotherapy for breast cancer: A prospective observational study
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Prevalence of Dermatologic Side Effects of Mood Stabilizers in Bipolar Disorder: A Systematic Review and A Meta-Analysis
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Gender differences in adverse effects and dosing practices of low-dose oral minoxidil for androgenetic alopecia: a retrospective analysis of 310 patients
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
- Adverse events related to platelet-rich plasma therapy and future issues to be resolved
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Are Pediatric GLP ‐1 Receptor Agonist Cutaneous Adverse Events Being Overlooked? Emerging Age‐Specific Patterns and Their Implications for Dermatologists
- Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
- No Association between Patient Demographics and Adverse Effects of Low-Dose Oral Minoxidil in a Retrospective Cohort study of Nonscarring Alopecia Patients
- Should Oral Minoxidil be Our First Choice for Treatment of Alopecia?
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review